Scientists have found that a large proportion of infants who suffer from bronchiolitis have an inherent pre-disposition to the disease.
The disease is the most prevalent acute wheezing disorder in infants and is the most common cause of admission to hospital in the first year of life in the developed world. Around 25 in every 1,000 babies are admitted to hospital for bronchiolitis - needing oxygen and help with feeding - and of these, 10% need the support of a ventilator.
Bronchiolitis frequently develops in infants suffering from respiratory syncytial virus (RSV) infection. Although most infants infected with RSV have only mild symptoms such as a cough and wheeze some develop potentially life-threatening bronchiolitis. Babies born prematurely are particularly susceptible to the condition but what has puzzled scientists is that the majority of babies admitted to hospital are previously healthy and have not had an obvious reason for becoming so ill.
A new study by University of Liverpool scientists, based at Alder Hey Children’s Hospital, has found that previously healthy babies with severe disease have a different immune response to those with only mild symptoms. The study involved nearly 200 infants under two years old admitted to Alder Hey over a five-year period. On admission to hospital, those with severe disease were taking more than 50 breaths per minute and their blood oxygen levels were dangerously low.
The study found that those with severe bronchiolitis had lower levels of interferon-gamma and substance P in their airway secretions. Gamma interferon is an important substance made in the body which is used to fight viral infections. The role of substance P is less understood but is thought to be involved in the local inflammatory response in many parts of the body.
Dr Calum Semple, Senior Lecturer in Child Health at the University of Liverpool and Consultant Respiratory Paediatrician based at Alder Hey, said: “This work helps to explain a common observation about children who had bronchiolitis as babies. Parents often tell us that every time their child gets a cold ‘it goes straight to his chest’ and many parents and doctors believe that bronchiolitis in infancy is the cause of these chest problems in childhood.
“This study shows that it is the difference in the child’s ability to fight viruses that predisposes them to bronchiolitis in the first place. That poor ability to fight the condition is an innate feature of their immune system. Bronchiolitis just happens to be the commonest respiratory virus around and therefore the first virus a baby is likely to come across.
“Because the gamma interferon response is an important feature of the immune system in these children, they won’t handle subsequent respiratory viruses very well either. The association between bronchiolitis in babies and ‘chestiness’ in childhood is not causal or consequential but due to a common immune predisposition and is probably genetic.”
Source: University of Liverpool
Related stories:
New agent strikes at respiratory syncytial virus replication
University of Texas Medical Branch at Galveston researchers have achieved promising results with a potential new weapon against respiratory syncytial virus, the most common cause of infant hospitalization in the United States.
Weak immune response critical to disease that causes most infant hospitalizations
The most common cause of infant hospitalization in the United States, respiratory syncytial virus, infects virtually all children by age two. Along with the influenza virus, RSV is a major contributor to the approximately two million infant deaths worldwide caused every year by respiratory infections, according to the World Health Organization. Worse yet, there’s no safe and effective RSV vaccine available to prevent severe respiratory infections, and no specific antiviral therapy to treat them.
Molecular imaging may lead to earlier diagnosis of childhood respiratory virus
Scientists have used a powerful molecular imaging technique to see inside living cells infected with the most pervasive and potentially fatal childhood respiratory virus known to medicine -- respiratory syncytial virus (RSV). The technique is yielding insight on viruses – such as RSV, human influenza, hepatitis C, West Nile virus and severe acute respiratory syndrome (SARS) -- that replicate with the help of proteins encoded by ribonucleic acid (RNA) inside the cell. Ultimately, the research could to lead to early and rapid detection of viral infection and the design of new antiviral drugs.
Study examines cold medication use in young children
Cough and cold medication use in young children has been linked to a significant number of adverse effects and several deaths, leading the FDA to recommend against their use for children less than two years old. Despite these concerns about safety and efficacy, there has been little research on patterns of cough and cold medication use in very young children. Now, a new study from the Emergency Medicine Network led by Katherine O’Donnell, M.D. of Children’s Hospital Boston reveals important new statistics about medication use in children under the age of two.
Rodent study finds artificial butter chemical harmful to lungs
A new study shows that exposure to a chemical called diacetyl, a component of artificial butter flavoring, can be harmful to the nose and airways of mice. Scientists at the National Institute of Environmental Health Sciences (NIEHS), part of the National Institutes of Health, conducted the study because diacetyl has been implicated in causing obliterative bronchiolitis (OB) in humans. OB is a debilitating but rare lung disease, which has been detected recently in workers who inhale significant concentrations of the flavoring in microwave popcorn packaging plants.
FDA approves new respiratory virus test
The U.S. Food and Drug Administration has approved a test that detects four respiratory viruses, including the flu, in a patient's respiratory secretions.
Could butter substitute make cooks sick?
U.S. restaurant cooks who spend hours at the stove could be at risk from a flavoring additive used in butter substitutes, a report says.
Alcohol may amplify chronic rejection in lung transplants
A recent study using an animal model of lung transplants shows that chronic alcohol consumption by the donor promotes scarring and airway injury after transplantation.